2026 ISPE Europe Annual Conference
Thank you to all who made the 2026 ISPE Europe Annual Conference such a big success!
Thank you to all who made the 2026 ISPE Europe Annual Conference such a big success!
Please Note:
- All full-access registration (virtual & in-person) includes access to speaker presentations, on-demand content, and other conference material.
- NOTE: Material is only available from those speakers/companies that permitted distribution.
- Registrants will receive email notification when the on-demand content is available.
- On-demand content is accessible for 90 days.
End Users and Thought Leaders Who Participated in the 2026 ISPE Europe Annual Conference
Conference Overview
20 - 22 Apr 2026 Copenhagen, Denmark and Virtual
The 2026 ISPE Europe Annual Conference brings together pharmaceutical and biopharmaceutical professionals from all levels of the industry – from students and emerging leaders to the most senior executives in drug manufacturing, supply chain, devices, equipment, and services, and global regulatory agencies.
This flagship event will explore how cutting-edge technologies, such as artificial intelligence and machine learning (AI/ML), virtual and augmented reality, and smart manufacturing, are reshaping our industry. We’ll also spotlight breakthroughs in biopharmaceuticals and Advanced Therapy Medicinal Products (ATMPs), and dive into practical strategies for addressing current challenges such as drug shortages and improving global access to medicines.
Participants will benefit from expert-led sessions on enhancing operational efficiency, ensuring project success, and sharing real-world case studies. Whether you’re here to discover emerging trends, contribute lessons learned, or benchmark best practices, the 2026 ISPE Europe Annual Conference offers a collaborative platform for driving innovation and excellence.
We look forward to your contribution and to collectively shaping the future of pharmaceutical and biopharmaceutical manufacturing at this year’s conference.
Featured Speakers
Image
Image
Conference Highlights
Podcast Preview: What to Look Forward to at the 2026 ISPE Europe Annual Conference
The pharmaceutical industry is undergoing one of the most intense periods of transformation in its history. Advances in science, the acceleration of digital technologies, evolving regulatory expectations, and mounting sustainability pressures are reshaping how medicines are developed and manufactured. Against this backdrop, the 2026 ISPE Europe Annual Conference promises to be a defining moment for industry professionals navigating this increasingly complex landscape.
Sustainability, Quality, and Project Excellence Take Center Stage at the 2026 ISPE Europe Annual Conference
From 20–22 April 2026, the 2026 ISPE Europe Annual Conference will bring pharmaceutical and biopharmaceutical professionals to Copenhagen, Denmark, for three days of focused discussion on the challenges shaping the future of regulated manufacturing. As sustainability expectations accelerate and project delivery pressures intensify, the conference program reflects a clear priority: translating innovation into practical, good manufacturing practices (GMP) ready solutions across the facility and project lifecycle.
From Validation 4.0 to Embedded Data Integrity: Practical Strategies for Pharma Transformation at the 2026 ISPE Europe Annual Conference
As pharmaceutical manufacturers accelerate digital transformation, many organizations face a familiar challenge: how to adopt modern technologies without increasing compliance risk or operational friction. The 2026 ISPE Europe Annual Conference brings industry leaders together to address exactly this tension—bridging innovation, quality, and regulatory expectations with proven, real-world approaches.
International Program Committee
Technology Manager Biotechnology
CRB Group GmbH
Board Liaison
Global Lead, Site Engineering, Synthetics
Johnson & Johnson
Affiliate Liaison
Sales Director
BWT Pharma & Biotech AB
Women in Pharma® Liaison
Strategic Marketing Manager
CRB
Life-Sciences Subject Matter Expert
Wood Plc
Head Life Sciences Process Department
Technip Energies
Senior Fellow - Digital Technology, Associate
CRB
Managing Director
Q-FINITY Quality Management
Qualified Person - Plant Manager
Lab. GP-Pharm
Program Leader
Eli Lilly Limited
External Affairs Director, Audits, Inspection & Quality Intelligence
Novo Nordisk
Technical Director - GMP / Regulatory Compliance
PM Group
Chief Strategy Officer
CAI
Managing Director
Memo3 GmbH
Chair
Director
TenTenTen Consulting Ltd
Emerging Leader
CSV/CSA and Data Integrity Expert
BLENDED Consulting BV
Emerging Leader
Engineering Manager
Meira GTx
Emerging Leader
Process Engineer
Technip Energies
Emerging Leader
Process Engineer MS&T Drug Substance
Takeda
Emerging Leader
Project Manager
Bayer AG
Emerging Leader
CQV Consultant
Independent Consultant